In fiscal year 2019 , the Japanese pharmaceutical company Takeda Pharmaceutical Co. , Ltd. recorded R & D expenses amounting to approximately 492 billion Japanese yen , up from around 368 billion yen in the previous year . The company focuses mainly on the therapeutic areas oncology , gastroenterology and neuroscience .
